EPOXIDES AND SOLUBLE EPOXIDE HYDROLASE IN CARDIOVASCULAR PHYSIOLOGY

被引:290
作者
Imig, John D. [1 ]
机构
[1] Med Coll Wisconsin, Cardiovasc Res Ctr, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
ARACHIDONIC-ACID EPOXYGENASE; BOVINE CORONARY-ARTERIES; VASCULAR SMOOTH-MUSCLE; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION; ACTIVATED-RECEPTOR-ALPHA; SALT-SENSITIVE HYPERTENSION; RED-BLOOD-CELLS; ASTROCYTIC EPOXYEICOSATRIENOIC ACID; RAT PREGLOMERULAR MICROVESSELS; INDUCED PULMONARY-HYPERTENSION;
D O I
10.1152/physrev.00021.2011
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Imig JD. Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology. Physiol Rev 92: 101-130, 2012; doi: 10.1152/physrev.00021.2011.-Epoxyeicosatrienoic acids (EETs) are arachidonic acid metabolites that importantly contribute to vascular and cardiac physiology. The contribution of EETs to vascular and cardiac function is further influenced by soluble epoxide hydrolase (sEH) that degrades EETs to diols. Vascular actions of EETs include dilation and angiogenesis. EETs also decrease inflammation and platelet aggregation and in general act to maintain vascular homeostasis. Myocyte contraction and increased coronary blood flow are the two primary EET actions in the heart. EET cell signaling mechanisms are tissue and organ specific and provide significant evidence for the existence of EET receptors. Additionally, pharmacological and genetic manipulations of EETs and sEH have demonstrated a contribution for this metabolic pathway to cardiovascular diseases. Given the impact of EETs to cardiovascular physiology, there is emerging evidence that development of EET-based therapeutics will be beneficial for cardiovascular diseases.
引用
收藏
页码:101 / 130
页数:30
相关论文
共 333 条
[1]  
Adeagbo ASO, 2001, EDHF 2000, P195
[2]   Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo [J].
Ai, Ding ;
Fu, Yi ;
Guo, Deliang ;
Tanaka, Hiromasa ;
Wang, Nanping ;
Tang, Chaoshu ;
Hammock, Bruce D. ;
Shyy, John Y. -J. ;
Zhu, Yi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (21) :9018-9023
[3]   Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy [J].
Ai, Ding ;
Pang, Wei ;
Li, Nan ;
Xu, Ming ;
Jones, Paul D. ;
Yang, Jun ;
Zhang, Youyi ;
Chiamvimonvat, Nipavan ;
Shyy, John Y. -J. ;
Hammock, Bruce D. ;
Zhu, Yi .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (02) :564-569
[4]   Neuroprotection and P4502C11 upregulation after experimental transient ischemic attack [J].
Alkayed, NJ ;
Goyagi, T ;
Joh, HD ;
Klaus, J ;
Harder, DR ;
Traystman, RJ ;
Hurn, PD .
STROKE, 2002, 33 (06) :1677-1684
[5]   Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats [J].
Alkayed, NJ ;
Birks, EK ;
Narayanan, J ;
Petrie, KA ;
KohlerCabot, AE ;
Harder, DR .
STROKE, 1997, 28 (05) :1066-1072
[6]   Role of EETs in regulation of endothelial permeability in rat lung [J].
Alvarez, DF ;
Gjerde, EAB ;
Townsley, MI .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 286 (02) :L445-L451
[7]   Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels [J].
Archer, SL ;
Gragasin, FS ;
Wu, XC ;
Wang, SH ;
McMurtry, S ;
Kim, DH ;
Platonov, M ;
Koshal, A ;
Hashimoto, K ;
Campbell, WB ;
Falck, JR ;
Michelakis, ED .
CIRCULATION, 2003, 107 (05) :769-776
[8]   Increased blood pressure in mice lacking cytochrome P450 2J5 [J].
Athirakul, Krairerk ;
Bradbury, J. Alyce ;
Graves, Joan P. ;
DeGraff, Laura M. ;
Ma, Jixiang ;
Zhao, Yun ;
Couse, John F. ;
Quigley, Raymond ;
Harder, David R. ;
Zhao, Xueying ;
Imig, John D. ;
Pedersen, Theresa L. ;
Newman, John W. ;
Hammock, Bruce D. ;
Conley, Alan J. ;
Korach, Kenneth S. ;
Coffman, Thomas M. ;
Zeldin, Darryl C. .
FASEB JOURNAL, 2008, 22 (12) :4096-4108
[9]  
BALAZY M, 1991, J BIOL CHEM, V266, P23561
[10]   Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury [J].
Batchu, S. N. ;
Lee, S. B. ;
Qadhi, R. S. ;
Chaudhary, K. R. ;
El-Sikhry, H. ;
Kodela, R. ;
Falck, J. R. ;
Seubert, J. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (04) :897-907